Technical Analysis for DXR - Daxor Corporation

Grade Last Price % Change Price Change
grade D 9.6 4.35% 0.40
DXR closed up 4.35 percent on Wednesday, November 13, 2019, on 60 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical DXR trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Bearish Engulfing Bearish 4.35%
Fell Below 20 DMA Bearish 4.35%
Fell Below 50 DMA Bearish 4.35%
MACD Bearish Signal Line Cross Bearish 4.35%
180 Bearish Setup Bearish Swing Setup 4.35%
Expansion Pivot Sell Setup Bearish Swing Setup 4.35%

Older signals for DXR ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Daxor Corporation, a medical device manufacturing company, offers biotech services in the United States. The company develops and markets BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients with heart failure, kidney failure, hypertension, and syncope; aid in fluid and blood transfusion management in the critical care unit; and aid in the diagnosis and treatment of disorders of red blood cell volume, including polycythemia and anemia, as well as used in pre-surgical evaluation of red blood cell volume. The company also provides cryobanking services, including blood and semen storage and related services. Daxor Corporation markets its products to hospitals and radiology imaging centers. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.
Medical Specialties Disorders Heart Failure Hypertension Blood Anemia Transfusion Medicine Hematology Science Blood Transfusion Kidney Failure Hematopathology Red Blood Cell Syncope
Is DXR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 19.95
52 Week Low 5.75
Average Volume 2,994
200-Day Moving Average 10.5712
50-Day Moving Average 9.434
20-Day Moving Average 9.4198
10-Day Moving Average 9.384
Average True Range 0.3156
ADX 14.55
+DI 22.573
-DI 26.3548
Chandelier Exit (Long, 3 ATRs ) 8.9832
Chandelier Exit (Short, 3 ATRs ) 10.066799999999999
Upper Bollinger Band 9.8071
Lower Bollinger Band 9.0325
Percent B (%b) 0.73
BandWidth 8.223105
MACD Line -0.0055
MACD Signal Line -0.0149
MACD Histogram 0.0094
Fundamentals Value
Market Cap 36.39 Million
Num Shares 3.79 Million
EPS -0.21
Price-to-Earnings (P/E) Ratio -45.71
Price-to-Sales 30.32
Price-to-Book 1.11
PEG Ratio 0.00
Dividend 0.03
Dividend Yield 0.31%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.90
Resistance 3 (R3) 9.92 9.85 9.85
Resistance 2 (R2) 9.85 9.77 9.84 9.83
Resistance 1 (R1) 9.72 9.72 9.69 9.70 9.82
Pivot Point 9.65 9.65 9.63 9.64 9.65
Support 1 (S1) 9.52 9.57 9.49 9.50 9.38
Support 2 (S2) 9.45 9.52 9.44 9.37
Support 3 (S3) 9.32 9.45 9.35
Support 4 (S4) 9.30